Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more

References

  • Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskeletal Disorders 2004; 26:5–6.
  • Kim J, Lee EY, Koh E, Cha H, Yoo B, Lee CK, Lee YL, Ryu H, Lee KH, Song YW. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomised, doubleblind, double-dummy, phase IV study in Korean participants. Clinical Therapeutics 2009; 31(12):2860–72.
  • Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. Journal of Family Practice 2002; 51(5):425–30.
  • Sarac AJ, Gur AJ. Complementary and alternative medical therapies in fibromyalgia. Current Pharmaceutical Design 2006; 12(1):47–57.
For more information, go to www.arthritisresearchuk.org.
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.